|
EconStor >
Institut für Weltwirtschaft (IfW), Kiel >
Kiel Advanced Studies Working Papers, IfW >
Please use this identifier to cite or link to this item:
http://hdl.handle.net/10419/27014
|
| | |
| Title: | | The national regulation of pharmaceutical markets and the timing of new drug launches in Europe  |
| Authors: | | Heuer, Alexander Mejer, Malwina Neuhaus, Jennifer |
| Issue Date: | | 2007 |
| Series/Report no.: | | Kiel advanced studies working papers 437 |
| Abstract: | | We analyze the impact of national pharmaceutical regulation on the launch delay of new chemical entities approved by the EMEA's centralized procedure. We find that direct price control regimes have a significantly negative impact on the launch timing. These results cannot be found when investigating the impact of indirect price controls. Our results show that Germany (65%) has the highest probability of experiencing an early launch, while it is the lowest in southern European countries (18% for Portugal and 19% for Greece). This difference accrues from both price regulation and market attractiveness, since southern European countries generally have lower prices. Due to the possibilities for parallel trade within the EU, pharmaceutical companies, by acting strategically, may further increase launch delays. |
| Subjects: | | pharmaceuticals regulation new chemical entity parallel trade |
| JEL: | | I11 I18 L51 |
| Document Type: | | Working Paper |
| Appears in Collections: | | Publikationen von Forscherinnen und Forschern des IfW Kiel Advanced Studies Working Papers, IfW
|
| Files in This Item:
| |
|
| No. of Downloads:
| |
| last Month |
last 3 Month |
total |
|
|
|
|
|
| |
| | |
Download bibliographical data as:
BibTeX
|
| |
Share on:http://hdl.handle.net/10419/27014
|
Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.
|